Report Detail

Request for Sample of this report

Other Global Cancer Gene Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

  • RnM4602243
    • |
  • 20 July, 2024
    • |
  • Global
    • |
  • 112 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Other

According to our (Global Info Research) latest study, the global Cancer Gene Therapy market size was valued at USD 537.1 million in 2023 and is forecast to a readjusted size of USD 1617.3 million by 2030 with a CAGR of 17.1% during review period.
Cancer could be defined as uncontrolled cell growth in the body leading to organ malfunction. If untreated, it can lead to death. Uncontrolled growth of cell is managed by the body in several ways, one of them is by deploying white blood cells to detect and eradicate these cancerous cells. It has been discovered that the immune system could be manipulated to influence cancerous cells to destroy itself.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Cancer Gene Therapy industry chain, the market status of Hospitals (Oncolytic Virotherapy, Gene Transfer), Diagnostics Centers (Oncolytic Virotherapy, Gene Transfer), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Cancer Gene Therapy.
Regionally, the report analyzes the Cancer Gene Therapy markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Cancer Gene Therapy market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Cancer Gene Therapy market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Cancer Gene Therapy industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Oncolytic Virotherapy, Gene Transfer).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Cancer Gene Therapy market.
Regional Analysis: The report involves examining the Cancer Gene Therapy market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Cancer Gene Therapy market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Cancer Gene Therapy:
Company Analysis: Report covers individual Cancer Gene Therapy players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Cancer Gene Therapy This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Diagnostics Centers).
Technology Analysis: Report covers specific technologies relevant to Cancer Gene Therapy. It assesses the current state, advancements, and potential future developments in Cancer Gene Therapy areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Cancer Gene Therapy market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Cancer Gene Therapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Oncolytic Virotherapy
Gene Transfer
Gene-Induced Immunotherapy
Market segment by Application
Hospitals
Diagnostics Centers
Research Institutes
Market segment by players, this report covers
Adaptimmune
Bluebird bio
Celgene
Shanghai Sunway Biotech
Shenzhen SiBiono GeneTech
SynerGene Therapeutics
Altor BioScience
Amgen
Argenx
BioCancell
GlaxoSmithKline
Merck
OncoGenex Pharmaceuticals
Transgene
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Cancer Gene Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cancer Gene Therapy, with revenue, gross margin and global market share of Cancer Gene Therapy from 2019 to 2024.
Chapter 3, the Cancer Gene Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Cancer Gene Therapy market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cancer Gene Therapy.
Chapter 13, to describe Cancer Gene Therapy research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Cancer Gene Therapy
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Cancer Gene Therapy by Type
    • 1.3.1 Overview: Global Cancer Gene Therapy Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Cancer Gene Therapy Consumption Value Market Share by Type in 2023
    • 1.3.3 Oncolytic Virotherapy
    • 1.3.4 Gene Transfer
    • 1.3.5 Gene-Induced Immunotherapy
  • 1.4 Global Cancer Gene Therapy Market by Application
    • 1.4.1 Overview: Global Cancer Gene Therapy Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospitals
    • 1.4.3 Diagnostics Centers
    • 1.4.4 Research Institutes
  • 1.5 Global Cancer Gene Therapy Market Size & Forecast
  • 1.6 Global Cancer Gene Therapy Market Size and Forecast by Region
    • 1.6.1 Global Cancer Gene Therapy Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Cancer Gene Therapy Market Size by Region, (2019-2030)
    • 1.6.3 North America Cancer Gene Therapy Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Cancer Gene Therapy Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Cancer Gene Therapy Market Size and Prospect (2019-2030)
    • 1.6.6 South America Cancer Gene Therapy Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa Cancer Gene Therapy Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Adaptimmune
    • 2.1.1 Adaptimmune Details
    • 2.1.2 Adaptimmune Major Business
    • 2.1.3 Adaptimmune Cancer Gene Therapy Product and Solutions
    • 2.1.4 Adaptimmune Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Adaptimmune Recent Developments and Future Plans
  • 2.2 Bluebird bio
    • 2.2.1 Bluebird bio Details
    • 2.2.2 Bluebird bio Major Business
    • 2.2.3 Bluebird bio Cancer Gene Therapy Product and Solutions
    • 2.2.4 Bluebird bio Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Bluebird bio Recent Developments and Future Plans
  • 2.3 Celgene
    • 2.3.1 Celgene Details
    • 2.3.2 Celgene Major Business
    • 2.3.3 Celgene Cancer Gene Therapy Product and Solutions
    • 2.3.4 Celgene Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Celgene Recent Developments and Future Plans
  • 2.4 Shanghai Sunway Biotech
    • 2.4.1 Shanghai Sunway Biotech Details
    • 2.4.2 Shanghai Sunway Biotech Major Business
    • 2.4.3 Shanghai Sunway Biotech Cancer Gene Therapy Product and Solutions
    • 2.4.4 Shanghai Sunway Biotech Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Shanghai Sunway Biotech Recent Developments and Future Plans
  • 2.5 Shenzhen SiBiono GeneTech
    • 2.5.1 Shenzhen SiBiono GeneTech Details
    • 2.5.2 Shenzhen SiBiono GeneTech Major Business
    • 2.5.3 Shenzhen SiBiono GeneTech Cancer Gene Therapy Product and Solutions
    • 2.5.4 Shenzhen SiBiono GeneTech Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Shenzhen SiBiono GeneTech Recent Developments and Future Plans
  • 2.6 SynerGene Therapeutics
    • 2.6.1 SynerGene Therapeutics Details
    • 2.6.2 SynerGene Therapeutics Major Business
    • 2.6.3 SynerGene Therapeutics Cancer Gene Therapy Product and Solutions
    • 2.6.4 SynerGene Therapeutics Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 SynerGene Therapeutics Recent Developments and Future Plans
  • 2.7 Altor BioScience
    • 2.7.1 Altor BioScience Details
    • 2.7.2 Altor BioScience Major Business
    • 2.7.3 Altor BioScience Cancer Gene Therapy Product and Solutions
    • 2.7.4 Altor BioScience Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Altor BioScience Recent Developments and Future Plans
  • 2.8 Amgen
    • 2.8.1 Amgen Details
    • 2.8.2 Amgen Major Business
    • 2.8.3 Amgen Cancer Gene Therapy Product and Solutions
    • 2.8.4 Amgen Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Amgen Recent Developments and Future Plans
  • 2.9 Argenx
    • 2.9.1 Argenx Details
    • 2.9.2 Argenx Major Business
    • 2.9.3 Argenx Cancer Gene Therapy Product and Solutions
    • 2.9.4 Argenx Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Argenx Recent Developments and Future Plans
  • 2.10 BioCancell
    • 2.10.1 BioCancell Details
    • 2.10.2 BioCancell Major Business
    • 2.10.3 BioCancell Cancer Gene Therapy Product and Solutions
    • 2.10.4 BioCancell Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 BioCancell Recent Developments and Future Plans
  • 2.11 GlaxoSmithKline
    • 2.11.1 GlaxoSmithKline Details
    • 2.11.2 GlaxoSmithKline Major Business
    • 2.11.3 GlaxoSmithKline Cancer Gene Therapy Product and Solutions
    • 2.11.4 GlaxoSmithKline Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 GlaxoSmithKline Recent Developments and Future Plans
  • 2.12 Merck
    • 2.12.1 Merck Details
    • 2.12.2 Merck Major Business
    • 2.12.3 Merck Cancer Gene Therapy Product and Solutions
    • 2.12.4 Merck Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Merck Recent Developments and Future Plans
  • 2.13 OncoGenex Pharmaceuticals
    • 2.13.1 OncoGenex Pharmaceuticals Details
    • 2.13.2 OncoGenex Pharmaceuticals Major Business
    • 2.13.3 OncoGenex Pharmaceuticals Cancer Gene Therapy Product and Solutions
    • 2.13.4 OncoGenex Pharmaceuticals Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 OncoGenex Pharmaceuticals Recent Developments and Future Plans
  • 2.14 Transgene
    • 2.14.1 Transgene Details
    • 2.14.2 Transgene Major Business
    • 2.14.3 Transgene Cancer Gene Therapy Product and Solutions
    • 2.14.4 Transgene Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.14.5 Transgene Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Cancer Gene Therapy Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Cancer Gene Therapy by Company Revenue
    • 3.2.2 Top 3 Cancer Gene Therapy Players Market Share in 2023
    • 3.2.3 Top 6 Cancer Gene Therapy Players Market Share in 2023
  • 3.3 Cancer Gene Therapy Market: Overall Company Footprint Analysis
    • 3.3.1 Cancer Gene Therapy Market: Region Footprint
    • 3.3.2 Cancer Gene Therapy Market: Company Product Type Footprint
    • 3.3.3 Cancer Gene Therapy Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Cancer Gene Therapy Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Cancer Gene Therapy Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Cancer Gene Therapy Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Cancer Gene Therapy Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Cancer Gene Therapy Consumption Value by Type (2019-2030)
  • 6.2 North America Cancer Gene Therapy Consumption Value by Application (2019-2030)
  • 6.3 North America Cancer Gene Therapy Market Size by Country
    • 6.3.1 North America Cancer Gene Therapy Consumption Value by Country (2019-2030)
    • 6.3.2 United States Cancer Gene Therapy Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Cancer Gene Therapy Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Cancer Gene Therapy Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Cancer Gene Therapy Consumption Value by Type (2019-2030)
  • 7.2 Europe Cancer Gene Therapy Consumption Value by Application (2019-2030)
  • 7.3 Europe Cancer Gene Therapy Market Size by Country
    • 7.3.1 Europe Cancer Gene Therapy Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Cancer Gene Therapy Market Size and Forecast (2019-2030)
    • 7.3.3 France Cancer Gene Therapy Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Cancer Gene Therapy Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Cancer Gene Therapy Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Cancer Gene Therapy Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Cancer Gene Therapy Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Cancer Gene Therapy Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Cancer Gene Therapy Market Size by Region
    • 8.3.1 Asia-Pacific Cancer Gene Therapy Consumption Value by Region (2019-2030)
    • 8.3.2 China Cancer Gene Therapy Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Cancer Gene Therapy Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Cancer Gene Therapy Market Size and Forecast (2019-2030)
    • 8.3.5 India Cancer Gene Therapy Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Cancer Gene Therapy Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Cancer Gene Therapy Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Cancer Gene Therapy Consumption Value by Type (2019-2030)
  • 9.2 South America Cancer Gene Therapy Consumption Value by Application (2019-2030)
  • 9.3 South America Cancer Gene Therapy Market Size by Country
    • 9.3.1 South America Cancer Gene Therapy Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Cancer Gene Therapy Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Cancer Gene Therapy Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Cancer Gene Therapy Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Cancer Gene Therapy Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Cancer Gene Therapy Market Size by Country
    • 10.3.1 Middle East & Africa Cancer Gene Therapy Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Cancer Gene Therapy Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Cancer Gene Therapy Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Cancer Gene Therapy Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Cancer Gene Therapy Market Drivers
  • 11.2 Cancer Gene Therapy Market Restraints
  • 11.3 Cancer Gene Therapy Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Cancer Gene Therapy Industry Chain
  • 12.2 Cancer Gene Therapy Upstream Analysis
  • 12.3 Cancer Gene Therapy Midstream Analysis
  • 12.4 Cancer Gene Therapy Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Cancer Gene Therapy. Industry analysis & Market Report on Cancer Gene Therapy is a syndicated market report, published as Global Cancer Gene Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Cancer Gene Therapy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,648.28
    		3,972.42
    		5,296.56
    		3,138.96
    		4,708.44
    		6,277.92
    		496,282.80
    		744,424.20
    		992,565.60
    		292,250.40
    		438,375.60
    		584,500.80
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo